New Prostate Cancer Research
For Immediate Press Release:
SCIENTIFIC PEER REVIEW OF CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS’ PROSTATE CANCER RESEARCH PROGRAM FOR THE DEPARTMENT OF DEFENSE
The Congressionally Directed Medical Research Programs’ (CDMRP) Prostate Cancer Research Program (PCRP)consumer advocate Dennis Golden recently participated in the evaluation of research application submitted to the PCRP. Dennis was nominated for participation in the program by The National Prostate Cancer Awareness Foundation (PCaAware) of Simsbury CT and Hartford Hospital, Hartford, CT. As a consumer reviewer, he was a full voting member (along with prominent scientists) at meeting to determine how the $100 million appropriated by Congress for Fiscal Year 2019 and will be spent on PCRPresearch.
Consumer reviewers are asked to represent the collective view of patients by preparing comments on the impact of research issues such as diagnosis, treatment and quality of life. When commenting on serving as a consumer reviewer, Dennis said that it is truly an honor to be part of this program and to gain an understanding of the work that is being done to help cure prostate cancer – the second leading killer of men next to lung cancer. It is not the so-called good cancer so many believe it to be
Consumer advocates and scientists have worked together in this unique partnership to evaluate the scientific merit of research applications since FY97. Colonel Stephen J Dalai, Director of the CDMRP, expressed his appreciation or the consumer advocate’s perspective during the scientific review sessions. “Consumer advocates are an integral part of the CDMRP’s scientific review process. They provide a key ingredient to the review process, the patients perspective, which is real and urgent. The collaboration of Consumer advocates alongside the scientists’ subject matter expertise is a truly unique collaboration that is difficult to find inmost medical research programs.
Scientists applying propose to fund research that will lead to the elimination of death from prostate cancer and enhance the wellbeing of Service members, Veterans, and all men experiencing the impact of the disease. The PCRP fills important gaps not addressed by other funding agencies by supporting groundbreaking, high-risk, high-gain research while encouraging out-of-the-box thinking.
More information about the CDMRP’s PCRP is available at the website:
https://cdmrp.army.mil/pcrp/default.
For more information on the Prostate Cancer Awareness Foundation visit https://PCaAware.org
Media Contact:
Jennie Mettert-Young
Public Affairs Specialist
Ripple Effect
Supporting the
Programs,
USAMRMC
301-619-9783
Jennie.L.Mettert-Young.ctr@mail.mil
Leave a Reply